Skip to main content

Animations

MJFF Publications

3131 - 3140 of 8808 Results
Title
Year
  • Year
  • 2023
  • 2021
  • 2022
  • 2020
  • 2023
  • 2020
  • 2022
  • 2021
  • 2019
  • 2025
  • Summary Details
    OPEN
    Title: American Football Play and Parkinson Disease Among Men
    Journal Name: JAMA Network Open
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1001/jamanetworkopen.2023.28644
    Citation Count: 17
  • Summary Details
    OPEN
    Title: The industrial solvent trichloroethylene induces LRRK2 kinase activity and dopaminergic neurodegeneration in a rat model of Parkinson's disease
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nbd.2021.105312
    Citation Count: 53
  • Summary Details
    OPEN
    Title: Increased Phospho‐AKT in Blood Cells from LRRK2 G2019S Mutation Carriers
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/ana.26469
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Microglia, inflammation and gut microbiota responses in a progressive monkey model of Parkinson's disease: A case series
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nbd.2020.105027
    Citation Count: 52
  • Summary Details
    OPEN
    Title: Genome-wide screen reveals Rab12 GTPase as a critical activator of Parkinson’s disease-linked LRRK2 kinase
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.7554/elife.87098
    Citation Count: 56
  • Summary Details
    OPEN
    Title: Levodopa-responsive progressive encephalomyelitis with rigidity and myoclonus associated with glycine receptor antibodies
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.11.008
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Progression of regional cortical cholinergic denervation in Parkinson’s disease
    Journal Name: Brain Communications
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/braincomms/fcac320
    Citation Count: 25
  • Summary Details
    OPEN
    Title: K2S2O8-mediated coupling of 6-amino-7-aminomethyl-thiazolino-pyridones with aldehydes to construct amyloid affecting pyrimidine-fused thiazolino-2-pyridones
    Journal Name: Organic & Biomolecular Chemistry
    Publisher: Royal Society of Chemistry (RSC)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1039/d1ob01580j
    Citation Count: 1
  • Summary Details
    RESTRICTED
    Title: Excessive daytime sleepiness is associated to the development of swallowing impairment in a cohort of early stage drug naïve Parkinson's disease patients
    Journal Name: Journal of the Neurological Sciences
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.jns.2019.116626
    Citation Count: 20
  • Summary Details
    OPEN
    Title: Magnetoelectric nanoparticle technology for mitigating motor deficits in Parkinsonian mice
    Journal Name: Brain Stimulation
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.brs.2025.08.008
    Citation Count: 1
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.